NIA Funding Line Policy for FY 2023. Update (3/31/2023): The information below reflects an update to the NIA funding policy for fiscal year (FY) 2023 in both the …Update (9/1/2022): The tables below were updated to reflect paylines for FY 2022 end of year. NIA and NIH received an appropriation through the H.R. 2471, the “Consolidated Appropriations Act, 2022,” which provides full-year funding through September 30, 2022. NIA will now pay FY 2022 non-competing awards at 100% of the committed level as shown in the Notice of Award. NIA plans to restore ...The following grants have been awarded through the South Africa – U.S. Program for Collaborative Biomedical Research. ... NIAID Funding News. Most Recent Edition. Browse by Edition Date. Search All Funding News. Clinical Trials. ... Pharmacometric optimization of second line drugs for MDR tuberculosis treatment: 1 R01 HD083047-01: GARCIA ...Direct costs of $150,000 in the first year and $100,000 in the second year. Up to $50,000 of the award can be spent on the PI's salary each year (exclusive of fringe benefits); the remainder is at the PI’s discretion to use the award per the research described in the application. (Salary for mentors, secretarial and administrative assistants ...Each fiscal year (FY), NIA sets initial paylines conservatively and sets final paylines later in the year. The links below detail the paylines for relevant grant programs for each fiscal year. NIA Funding Line Policy for FY 2024. NIA Funding Line Policy for FY 2023. NIA Funding Line Policy for FY 2022. NIA Funding Line Policy for FY 2021.Applications with a Percentile Score. For percentiled AD/ADRD applications submitted to the Parent R01, R03, and R15 funding opportunities, NINDS follows the same AD/ADRD paylines as NIA. Parent Announcement. Applications. AD/ADRD Payline <$5M. AD/ADRD Payline ≥$5M.Building on many years of previous research on SARS, MERS, and other related viruses, NIAID scientists and collaborators were well-positioned to rapidly develop and advance clinical trials of COVID-19 vaccines, eventually enabling the authorization and widespread use of multiple vaccines in the United States and around the world. View the timeline …NIH published the notice of funding opportunity (NOFO) PAR-23-109, NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) on March 10, 2023. Refer to the NIH Medical Scientist Partnership Program (MSPP) Application Guide.. Updated April 2, 2024. We updated the answers to several questions, added a few new …At each Council session, scientific subcommittees review and approve concepts for NIAID initiatives, which are targeted research funding opportunities. While not all approved concepts become funding opportunities ultimately, concepts highlight the Institute’s research interests and can be good topics for investigator-initiated applications. Submitting an Application. Take action to prepare for your application's submission by understanding timelines and due dates, learn how to comply with technical requirements, and learn what to do if your application isn't funded. Preliminary information for researchers planning to apply for NIAID grant funding. As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency. For decades, NIAID has launched major research responses and …NIH published the notice of funding opportunity (NOFO) PAR-23-109, NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) on March 10, 2023.Refer to the NIH Medical Scientist Partnership Program (MSPP) Application Guide.Financial Management Plan. Here NIAID sets fiscal year (FY) 2024 funding levels for grants, renewal cap, and selective pay and bridge pools. We update this page and the NIAID Paylines every FY. Our most recent update was on April 3, 2024: We updated the section below on noncompeting awards. NIH has an appropriation for FY 2024. …Oct 5, 2022 · As a result, NIAID generally does not set final paylines until after the final CR ends and we get the annual budget appropriation. Once NIAID no longer expects a payline number to change, we switch the payline’s status from interim to final on the Paylines page. Updated September 6, 2023. NIAMS FY 2023 Enacted Level: $685,465,000. NIAMS is operating under the FY 2023 Consolidated Appropriations Act signed by President Biden on December 29, 2022. The interim funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors ...May 3, 2024 · Facebook Email Print. Updated May 3, 2024. NIAMS FY 2024 Enacted Level: $685,465,000. NIAMS is operating under the Further Consolidated Appropriations Act, 2024 (Public Law 118-47) signed by President Biden on March 23, 2024. The funding plan below for research and training grants represents the most current information as of the date cited ... Illustrated Application and Grant Timelines. Check your action items for each phase of the grant process. For applications funded on the first try, it typically takes between 8 and 20 months after the due date to get an award. Some Deadlines Are Before the Application Due Date. Find examples of institutional and NIH deadlines for key steps in ...Financial Management Plan. Here NIAID sets fiscal year (FY) 2024 funding levels for grants, renewal cap, and selective pay and bridge pools. We update this page and the NIAID Paylines every FY. Our most recent update was on April 3, 2024: We updated the section below on noncompeting awards. NIH has an appropriation for FY 2024. …The D&B number should be entered on line 11 of the face page of the PHS 398 form. ... Release of each funding increment by NIAID will be based on a NIAID review of progress towards achieving the previously agreed upon interim objective. NIAID may ask recipients to collaborate or cooperate with other NIAID funded projects, and/or other US ...Interim FY24 funding line policy updateDecember 14, 2023. Interim FY24 funding line policy update. Kenneth SANTORA, Director, Division of Extramural Activities (DEA). Budget, Paylines, and Funding Policy. As promised in my October blog, NIA will share updates on our interim fiscal year (FY) 2024 funding line policy once decisions have been ...NIAID has a robust suite of funding opportunities and resources to facilitate investigator-initiated clinical trials (IICTs), which are indexed and described at Investigator-Initiated Clinical Trial Resources.Notably, we maintain a consultation process designed to help potential applicants identify an appropriate notice of funding opportunity (NOFO), …This article might complicate how you think of NIAID Paylines, which are funding cut-off points for grant applications. Specifically, the payline posted when you apply for a grant may well shift by the time NIAID is ready to issue an award, as the next fiscal year’s appropriation and the volume of incoming applications can impact our paylines ... Jeanne Marrazzo, M.D., M.P.H. Dr. Marrazzo steps in as the sixth NIAID Director in the fall of 2023, where she oversees a $6.3 billion budget that supports research to advance the understanding, diagnosis, and treatment of infectious, immunologic, and allergic diseases. She is internationally recognized for her research and education efforts in ... NIA and NIH received an appropriation through H.R. 6119 - Further Extending Government Funding Act, which was signed into law on Dec. 3, 2021, and …NIAID’s No-Cost Extension SOP puts it more simply, describing it as a way “to extend a grant's project period without additional funding.” Within an NCE, your project’s originally approved scope cannot change. That means you may not use an NCE to pursue a new line of investigation at the twilight of a project period.If your research interests center on data science, contact NIAID’s Office of Data Science and Emerging Technologies. If you are a foreign researcher with general questions about NIAID, contact our Office of Global Research. If your goal is to work in one of NIAID’s intramural laboratories, contact the NIAID Employment Outreach Team.Remember, paylines represent funding cutoff points. Each fiscal year, NIAID sets conservative interim paylines before ultimately determining final paylines. This approach allows us to award top-scoring applications throughout the fiscal year rather than waiting until the end of the fiscal year (once every application has been reviewed and ...Credit: NIAID. The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities. With the ultimate goal of creating ...We have now finalized fiscal year 2023 NIAID Paylines for each activity code in which NIAID uses a payline. Find background information at Understand Paylines and Percentiles . Keep in mind, we use percentiles for the R01 paylines …Global research is an integral part of many research projects, programs, initiatives, and other activities implemented by the NIAID extramural and intramural divisions. Conducting research in international settings allows NIAID-supported scientists to study infectious diseases and immunology under a variety of environmental and social conditions.They provide NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for R03 or R21 support at some point during the final two years of their K award. NIAID seeks to enhance the capability of these award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support).An NIAID Clinical Trial Planning Grant (R34) provides principal investigators with funds to prepare 1) materials NIAID needs to determine a project's feasibility and 2) documentation required for applying for an NIAID clinical trial implementation grant (R01), cooperative agreement (U01), or SBIR Phase II award (U44).As stated in our interim Financial Management Plan, NIAID will fund competing and noncompeting grants at 90 percent of approved and committed funding levels, respectively.NIAID will reconsider final funding levels for awards following the enactment of fiscal year (FY) 2024 appropriations, which may result in upward …Edition: May 1, 2024. NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff.In the blog post “How Grant Success Rates Do (Or Do Not) Track With the NIH Budget: A Model of Funding Dynamics,” he builds a scenario around a hypothetical funding agency that receives a constant annual budget and a constant incoming application volume to make a constant number of awards (which are assumed to all be the same …The National Heart, Lung, and Blood Institute (NHLBI) applies NIH cost management guidelines when making FY2024 grant awards (see NOT-OD-24-109 ). Legislative mandates for FY2024 are in effect (see NOT-OD-24-110 ). The salary limitation set at Executive Level II of the Federal Pay Scale is $221,900, effective with grant awards with an initial ...Individual funding institutions set their paylines or impact scores as follows: NCI. SBIR R43/R44: 23 (experienced as low as this figure) STTR R41/R42: <25 (experienced as low as this figure) Note, paylines are not published but Grant Engine experience demonstrates these paylines a reliable but not always definitive.Rebudgeting funds in or out of a budget category by more than 25 percent of the total costs of the award. Rebudgeting funds so that an alterations and renovations project exceeds $500,000. For a list of all actions that constitute a change in scope, see Section 8 of the NIH Grants Policy Statement.To address this growing problem, NIAID is funding and conducting research to better understand how microbes develop and pass on resistance genes. NIAID is also supporting the development of new and faster diagnostic tests to make it easier for doctors to prescribe the most effective drug. NIAID’s research program also focuses on ways to ...NIA and NIH received an appropriation through H.R. 6119 - Further Extending Government Funding Act, which was signed into law on Dec. 3, 2021, and …SPR720 is an investigational, novel, oral, first-line treatment for NTM-PD. Top-line data from the Phase 2a proof-of-concept clinical trial are expected in 2H 2024.A list of contact information for the various NIAID Division of AIDS (DAIDS) branches and programs. A list of contact information for the various NIAID Division of AIDS (DAIDS) branches and programs. ... NIAID Funding News. Most Recent Edition. Browse by Edition Date. Search All Funding News. Clinical Trials. Find a Clinical Trial.They provide NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for R03 or R21 support at some point during the final two years of their K award. NIAID seeks to enhance the capability of these award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support).We have now finalized fiscal year 2023 NIAID Paylines for each activity code in which NIAID uses a payline. Find background information at Understand Paylines and Percentiles . Keep in mind, we use percentiles for the R01 paylines and overall impact scores for every other activity code.Funding added to an existing grant or cooperative agreement. NIAID supports three types of supplements: administrative, research, and revision (competing). See the following pages: Administrative supplements add money to a grant without peer review to pay for unforeseen items within the scope of an award. 10% reduction for competing awards to the parent R21 NOFOs ( PA-20-194 and PA-20-196) All other R21s, no reduction. R03, R15. Select Pay 2. No reduction. P41. Select Pay 2. 10% reduction for competing awards applied to the first-year budget period ($500K equipment allowance excluded) Bioengineering Partnerships with Industry U01s. The new awards build on the $1.2 billion investment NIAID has made in coronavirus vaccine research since the COVID-19 pandemic began, including multiple projects in pan-coronavirus vaccine research in the NIAID intramural and extramural programs. A key goal of the initiative is to develop multivalent vaccine platforms and … Grants & Contracts Find a Funding Opportunity Types of Funding Opportunities Training and Career Development Grant Programs Research Career Development (K) Awards NIAID offers a variety of individual research career development (K) awards, which enable scientists with diverse backgrounds to enhance their careers in biomedical research. Building on many years of previous research on SARS, MERS, and other related viruses, NIAID scientists and collaborators were well-positioned to rapidly develop and advance clinical trials of COVID-19 vaccines, eventually enabling the authorization and widespread use of multiple vaccines in the United States and around the world. View the timeline …Notice of Funding Opportunity. Mentored Clinical Scientist Research Career Development Award (Parent K08, Independent Clinical Trial Not Allowed) Award Specifics. Duration of 3 to 5 years, not renewable. Award length depends on experience. Salary up to $100,000 (if institutional base salary is equivalent or more) plus fringe benefits.Timeline for Funding Decisions. You send just-in-time information and help resolve bars to award. NIAID staff make final funding decisions. It typically takes between 8 and 20 months after the due date to get an award. The darkened section of the graphic marks this phase of the process. Find other phases at Illustrated Application and Grant ...NIA Final Funding Line Policy for FY 2021. NIA and NIH received an appropriation through H.R.133 - The Consolidated Appropriations Act, 2021 that was signed into law on …Applicant ProfileNIAID makes very few awards for the Parent K99/R00 and the Physician-Scientist (PS) K99/R00. Therefore, you may want to consider applying for a Career Transition Award (K22) instead if you are a U.S. citizen or permanent resident.To qualify for a K99/R00, you must have plans to apply for a tenure-track (or equivalent) assistant professorship at a U.S. academic institution. You ...The COVID-19 pandemic impacted NIAID’s extramural funding patterns, interrupting what had been steady trendlines of application and award counts from FY 2013 through FY 2019. Having passed through several years of tumult, any new assessment of long-term trends will need to account for fluctuations during the pandemic. NIAID plans to leverage existing infrastructure and network sites to implement a structured program evaluating up to 10 next generation COVID-19 vaccines in Phase 1 and Phase 2 clinical trials. The studies will be sponsored by NIAID using common protocols and centralized assays of multiple immune parameters including humoral, cellular, and ... Timeline for Funding Decisions. You send just-in-time information and help resolve bars to award. NIAID staff make final funding decisions. It typically takes between 8 and 20 months after the due date to get an award. The darkened section of the graphic marks this phase of the process. Find other phases at Illustrated Application and Grant ...NIAID offers a variety of individual research career development (K) awards, which enable scientists to enhance their careers in biomedical research. ... You can search for All NIAID Career (K) Funding Opportunities on our Opportunities list. Except for the K99/R00 programs, all K awards require either U.S. citizenship or permanent residency ...An Analysis: Evolutionary Distance of SARS-CoV-2 and Bat Coronaviruses Studied Under the NIH-supported Research Grant to EcoHealth Alliance The research that NIH approved under the grant to EcoHealth Alliance with a subaward to the Wuhan Institute of Virology in Wuhan, China sought to understand how animal coronaviruses, especially bat coronaviruses, evolve naturally in the environment and ...Each fiscal year (FY), NIA sets initial paylines conservatively and sets final paylines later in the year. The links below detail the paylines for relevant grant programs for each fiscal year. NIA Funding Line Policy for FY 2024. NIA Funding Line Policy for FY 2023. NIA Funding Line Policy for FY 2022. NIA Funding Line Policy for FY 2021.As stated in our interim Financial Management Plan, NIAID will fund competing and noncompeting grants at 90 percent of approved and committed funding levels, respectively. NIAID will reconsider final funding levels for awards following the enactment of fiscal year (FY) 2024 appropriations, which may result in upward adjustments for some awards.Interim FY24 funding line policy updateDecember 14, 2023. Interim FY24 funding line policy update. Kenneth SANTORA, Director, Division of Extramural Activities (DEA). Budget, Paylines, and Funding Policy. As promised in my October blog, NIA will share updates on our interim fiscal year (FY) 2024 funding line policy once decisions have been ...NIH policy is that Funding Opportunity Announcements (FOAs) are typically active for no more than 3 years. Thus the expiration date is typically 3 years and 1 day after the first submission date. Note that, if the FOA accepts submissions on AIDS dates, the FOA will expire after the last AIDS submission date. Close.NIAID plans to leverage existing infrastructure and network sites to implement a structured program evaluating up to 10 next generation COVID-19 vaccines in Phase 1 and Phase 2 clinical trials. The studies will be sponsored by NIAID using common protocols and centralized assays of multiple immune parameters including humoral, cellular, and ...Understand NIAID Research Priorities. To maximize your chance of funding, create an application that fits NIAID research priorities. Review Council-approved concepts, find clues in our initiative list, check NIH databases, and contact a NIAID program officer. Concepts: Potential Opportunities.ImmPort is a Web portal that contains data from NIAID-funded immunology studies, including basic research and clinical trials. The portal provides online tools that allow users to analyze the data and visualize the results. ImmPort enables the integration of data from a variety of laboratories and supports collaboration between scientists, helping to generate …Access Clinical Trials Data. NIAID Clinical Trials Data Repository, AccessClinicalData@NIAID, is an NIAID cloud-based, secure data platform that enables sharing of and access to anonymized individual, patient level clinical data sets from NIAID sponsored clinical trials to harness the power of data to generate new knowledge to understand, treat ...Jun 15, 2022 · Remember, paylines represent funding cutoff points. Each fiscal year, NIAID sets conservative interim paylines before ultimately determining final paylines. This approach allows us to award top-scoring applications throughout the fiscal year rather than waiting until the end of the fiscal year (once every application has been reviewed and ... 10% reduction for competing awards to the parent R21 NOFOs ( PA-20-194 and PA-20-196) All other R21s, no reduction. R03, R15. Select Pay 2. No reduction. P41. Select Pay 2. 10% reduction for competing awards applied to the first-year budget period ($500K equipment allowance excluded) Bioengineering Partnerships with Industry U01s. Edition: May 1, 2024. NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff. You can subscribe directly by entering your email address at Email Updates and then selecting your subscription topics. We update all the pages in NIAID’s Paylines & Funding section as soon as we get new information. Learn more below about the typical timing for these updates. Fiscal Year Updates. Each fiscal year, the timing of our annual budget appropriation varies. We update the NIAID Paylines and Financial Management Plan as the year progresses. While this ... SPR720 is an investigational, novel, oral, first-line treatment for NTM-PD. Top-line data from the Phase 2a proof-of-concept clinical trial are expected in 2H 2024.Jun 12, 2023 · Recognizing the diversity of the grant portfolio, NINDS views paylines as the fairest way to make most funding decisions. A numerical value lets the Institute cut across disciplines and fund the best science as determined by peer review. It is important to remember that paylines vary among NIH institutes, so a percentile or overall priority ... NIAID provides research grants and contracts to support investigators at universities and other external organizations who conduct basic and applied research to understand, treat, and prevent infectious, immunologic, and allergic diseases. The scientific discoveries and resources supported through grants and contracts have helped NIAID improve ... Paylines—either percentiles (R01s only) or overall impact score order—are the funding cutoff points for investigator-initiated applications. We’ve recently updated our interim NIAID Paylines for research project grant (R), small business innovation research (SBIR), and small business technology transfer (STTR) awards.Grants Basics. Types of Grant Programs. NIH Exploratory/Developmental Research Grant Award (R21) Introduction. The R21 grant mechanism is intended to …Mar 6, 2024 · Credit: NIAID. The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities. With the ultimate goal of creating ... General NIAID Contact Info. Email: [email protected]. Due to the large volume of inquiries, our response may be significantly delayed. Phone: Toll-Free: 866-284-4107. Local: 301-496-5717. TDD: 800-877-8339 (for deaf or hard of hearing) Fax: 301-402-3573.Interim FY24 funding line policy updateDecember 14, 2023. Interim FY24 funding line policy update. Kenneth SANTORA, Director, Division of Extramural Activities (DEA). Budget, Paylines, and Funding Policy. As promised in my October blog, NIA will share updates on our interim fiscal year (FY) 2024 funding line policy once decisions have been ...Rebudgeting funds in or out of a budget category by more than 25 percent of the total costs of the award. Rebudgeting funds so that an alterations and renovations project exceeds $500,000. For a list of all actions that constitute a change in scope, see Section 8 of the NIH Grants Policy Statement.Review Cycle 2: January 27, 2025. Review Cycle 3: June 2, 2025. After Council, we may ask you to Respond to Pre-Award Requests (“Just-in-Time”). Step 8. NIAID funds selective pay and non-expedited awards. Review Cycle 1: October 2024, assuming we have a budget by then, through end of fiscal year.Paylines are the funding cutoff points for grant applications. Following the paylines, NIAID funds most applications in percentile (for R01s only) or overall impact score order (for others).Timeline for Funding Decisions. You send just-in-time information and help resolve bars to award. NIAID staff make final funding decisions. It typically takes between 8 and 20 months after the due date to get an award. The darkened section of the graphic marks this phase of the process. Find other phases at Illustrated Application and Grant ...NIH published PAR-24-099, NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44, Clinical Trial Required) notice of funding opportunity (NOFO) on January 29, 2024.
Figure 1: NIH RPG Applications and Awards for the FY 2005 Through FY 2007 NIAID K Cohorts . These NIAID K outcomes are consistent with other research career development assessments such as the NIH K Awards Evaluation, Final Report, 2011 (PDF) and the Bol, Thijs, et. al, The Matthew Effect in Science Funding, PNAS, 2018. After the First .... Spire gas co
Paylines—either percentiles (R01s only) or overall impact score order—are the funding cutoff points for investigator-initiated applications. We’ve recently updated our interim NIAID Paylines for research project grant (R), small business innovation research (SBIR), and small business technology transfer (STTR) awards.NIAID has awarded 11 new cooperative agreements to support the Consortium for Food Allergy Research, or CoFAR, in the latest renewal of the program since its establishment 19 years ago. The institute expects to fund the awards with more than $11 million annually for seven years, contingent upon the availability of funds.NIH published the notice of funding opportunity (NOFO) PAR-23-109, NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) on March 10, 2023. Refer to the NIH Medical Scientist Partnership Program (MSPP) Application Guide.. Updated April 2, 2024. We updated the answers to several questions, added a few new … This funding strategy will be updated when FY 2023 appropriations are enacted, and final funding policies are determined. Non-Competing Continuation Research Awards Until the FY 2023 appropriation is finalized, NIH will issue non-competing continuation research awards at a level below the amount indicated on the most recent Notice of Award ... The COVID-19 pandemic impacted NIAID’s extramural funding patterns, interrupting what had been steady trendlines of application and award counts from FY 2013 through FY 2019. Having passed through several years of tumult, any new assessment of long-term trends will need to account for fluctuations during the pandemic.In today’s digital age, crowdfunding has become an immensely popular way for individuals and organizations to raise funds for various causes. One of the most widely used platforms ...Cost of funds is calculated by taking the total annualized interest expense divided by average interest bearing deposits and other interest bearing borrowings, plus non-interest be...An NIAID Clinical Trial Planning Grant (R34) provides principal investigators with funds to prepare 1) materials NIAID needs to determine a project's feasibility and 2) documentation required for applying for an NIAID clinical trial implementation grant (R01), cooperative agreement (U01), or SBIR Phase II award (U44).Access Clinical Trials Data. NIAID Clinical Trials Data Repository, AccessClinicalData@NIAID, is an NIAID cloud-based, secure data platform that enables sharing of and access to anonymized individual, patient level clinical data sets from NIAID sponsored clinical trials to harness the power of data to generate new knowledge to understand, treat ...Jan 29, 2024 · The NIAID Clinical Trial Implementation (U01) Cooperative Agreement is designed to support high-risk clinical trials, as defined by NIAID below and in the associated policy statement (see NOT-AI-21-037 ). For non-high-risk trials, NIAID invites applications for two NIH Clinical Trial NOFOs, NIH Research Project Grant (Parent R01 Clinical Trials ... Timeline for Funding Decisions. You send just-in-time information and help resolve bars to award. NIAID staff make final funding decisions. It typically takes between 8 and 20 months after the due date to get an award. The darkened section of the graphic marks this phase of the process. Find other phases at Illustrated Application and Grant ...You can find your PO's contact information in your eRA Commons account or on your summary statement. Learn more about how and when to contact a program officer or grants management specialist. Content last reviewed on October 18, 2022. Fiscal year (FY) NIAID paylines and financial information for researchers after grant application submission.NIA Funding Line Policy for FY 2022. Update (9/1/2022): The tables below were updated to reflect paylines for FY 2022 end of year. NIA and NIH received an …Financial Management Plan. Here NIAID sets fiscal year (FY) 2024 funding levels for grants, renewal cap, and selective pay and bridge pools. We update this page and the NIAID Paylines every FY. Our most recent update was on April 3, 2024: We updated the section below on noncompeting awards. NIH has an appropriation for FY 2024. ….